First Calif. Zantac Cancer Trial Ends in Mistrial, Jury Split on Causation




OAKLAND, Calif. — A California judge has declared a mistrial after jurors were split 6-6 on whether Zantac (ranitidine) that had been allegedly contaminated with high levels of N-Nitrosodimethylamine (NDMA) caused the plaintiff’s bladder cancer diagnosis.

On Nov. 21, Judge Noël Wise of the Alameda County (Calif.) Superior Court issued the ruling in the first Zantac cancer case in the state to go to trial, and the first against Boehringer Ingelheim Pharmaceuticals to involve punitive damages.

Trial began on Oct. 3 and the jury deliberated for seven days before informing Judge Wise that they could not reach an agreement …

FIRM NAMES
  • Moore Law Group PLLC
  • Wisner Baum LLP





UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS